- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Torrent Pharma shareholders have approved Aman Mehta's appointment as Managing Director for five years, starting August 1, 2025. Previously a Whole-time Director, Mehta has been a key driver of the company's strategic growth. His impact includes successful acquisition integrations (Unichem, Curatio), significant field force expansion from 3,600 to 6,400 MRs by FY25, and a notable turnaround in the cardiac portfolio. He also propelled the diabetes segment's rank from 11th to 6th. His leadership across R&D and operations has boosted productivity and cost efficiency, setting the stage for future value creation.